New Therapies for Rheumatoid Arthritis.
作者信息
Kumar A, Marwaha V
机构信息
Addl Professor & Head, All India Institute of Medical Sciences, New Delhi.
Fellow in Rheumatology, Clinical Immunology and Rheumatology Service, Department of Medicine, All India Institute of Medical Sciences, New Delhi.
出版信息
Med J Armed Forces India. 2003 Apr;59(2):90-2. doi: 10.1016/S0377-1237(03)80045-X. Epub 2011 Jul 21.
Abstract
摘要
相似文献
1
New Therapies for Rheumatoid Arthritis.类风湿关节炎的新疗法
Med J Armed Forces India. 2003 Apr;59(2):90-2. doi: 10.1016/S0377-1237(03)80045-X. Epub 2011 Jul 21.
2
Strategies for the management of rheumatoid arthritis.类风湿关节炎的管理策略
Orthopedics. 2012 Feb;35(2):125-30. doi: 10.3928/01477447-20120123-36.
3
B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti-TNF-α Agents on B Lymphocytes: A Review of the Literature.类风湿关节炎中的 B 淋巴细胞及抗 TNF-α 药物对 B 淋巴细胞的影响：文献综述。
Clin Ther. 2018 Jun;40(6):1034-1045. doi: 10.1016/j.clinthera.2018.04.016. Epub 2018 May 23.
4
[Medical audit guideline about rheumatoid arthritis diagnosis and treatment.].[关于类风湿性关节炎诊断与治疗的医学审计指南。]
Rev Fac Cien Med Univ Nac Cordoba. 2019 Feb 27;76(1):68-76. doi: 10.31053/1853.0605.v76.n1.22218.
5
Rheumatoid arthritis: what do MRI and ultrasound show.类风湿性关节炎：磁共振成像和超声检查显示了什么。
J Ultrason. 2017 Mar;17(68):5-16. doi: 10.15557/JoU.2017.0001. Epub 2017 Mar 31.
6
The role of T cells in rheumatoid arthritis: new subsets and new targets.T细胞在类风湿性关节炎中的作用：新亚群与新靶点。
Curr Opin Rheumatol. 2007 May;19(3):284-8. doi: 10.1097/BOR.0b013e32805e87e0.
7
Identification of new susceptibility markers for rheumatoid arthritis and systemic lupus erythematosus in the STAT4 gene.在信号转导和转录激活因子4（STAT4）基因中鉴定类风湿关节炎和系统性红斑狼疮的新易感标记。
Per Med. 2008 Mar;5(2):169-174. doi: 10.2217/17410541.5.2.169.
8
Interleukin-6 in rheumatoid arthritis.类风湿关节炎中的白细胞介素-6
Curr Opin Rheumatol. 2006 May;18(3):277-81. doi: 10.1097/01.bor.0000218949.19860.d1.
9
Emerging biologic therapies in rheumatoid arthritis: cell targets and cytokines.类风湿关节炎中新兴的生物疗法：细胞靶点和细胞因子。
Curr Opin Rheumatol. 2005 May;17(3):274-9. doi: 10.1097/01.bor.0000160778.05389.dc.
10
Drug development in rheumatoid arthritis.类风湿关节炎的药物研发
Curr Opin Rheumatol. 2002 May;14(3):276-80. doi: 10.1097/00002281-200205000-00014.
引用本文的文献
1
Quality of Care in Rheumatoid Disease from the Clinician Perspective: A Modified Delphi Panel Approach.从临床医生角度看类风湿病的医疗质量：一种改良的德尔菲专家小组法
Rheumatol Ther. 2018 Jun;5(1):87-98. doi: 10.1007/s40744-018-0107-5. Epub 2018 Apr 3.
2
Evaluation of the concomitant use of methotrexate and curcumin on Freund's complete adjuvant-induced arthritis and hematological indices in rats.评价甲氨蝶呤和姜黄素联用对完全弗氏佐剂诱导的关节炎大鼠及血液学指标的影响。
Indian J Pharmacol. 2011 Sep;43(5):546-50. doi: 10.4103/0253-7613.84970.
本文引用的文献
1
Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells.选择性B细胞阻断在类风湿关节炎治疗中的疗效：B细胞致病作用的证据
Arthritis Rheum. 2002 Aug;46(8):2029-33. doi: 10.1002/art.10467.
2
Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies.近期发病的类风湿关节炎患者的早期治疗与延迟治疗：接受不同治疗策略的两个队列的比较。
Am J Med. 2001 Oct 15;111(6):446-51. doi: 10.1016/s0002-9343(01)00872-5.
3
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.与英夫利昔单抗（一种肿瘤坏死因子α中和剂）相关的结核病。
N Engl J Med. 2001 Oct 11;345(15):1098-104. doi: 10.1056/NEJMoa011110.
4
Management of rheumatoid arthritis: the historical context.类风湿关节炎的管理：历史背景
J Rheumatol. 2001 Jun;28(6):1431-52.
5
Consensus recommendations for the assessment and treatment of rheumatoid arthritis.类风湿关节炎评估与治疗的共识性建议。
J Rheumatol. 2001 Jun;28(6):1423-30.
6
Potential biologic agents for treating rheumatoid arthritis.治疗类风湿关节炎的潜在生物制剂。
Rheum Dis Clin North Am. 2001 May;27(2):445-91. doi: 10.1016/s0889-857x(05)70212-x.
7
Rheumatoid arthritis. From bench to bedside.类风湿关节炎。从实验室到临床。
Rheum Dis Clin North Am. 2001 May;27(2):373-87. doi: 10.1016/s0889-857x(05)70207-6.
8
Rational use of new and existing disease-modifying agents in rheumatoid arthritis.类风湿关节炎中新药和现有病情缓解药物的合理使用。
Ann Intern Med. 2001 Apr 17;134(8):695-706. doi: 10.7326/0003-4819-134-8-200104170-00013.
9
Renal effects of COX-2-selective inhibitors.COX-2选择性抑制剂的肾脏效应。
Am J Nephrol. 2001 Jan-Feb;21(1):1-15. doi: 10.1159/000046212.
10
Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD Study.印度西部农村人口中风湿性疾病的患病率：一项世界卫生组织 - 国际抗风湿病联盟社区导向的基层医疗研究（COPCORD研究）
J Assoc Physicians India. 2001 Feb;49:240-6.
Zotero 插件